What is Cognivia?
Cognivia, formerly Tools4Patient, is a company dedicated to accelerating patient access to novel therapies. It addresses critical challenges in drug development by offering a comprehensive suite of solutions that span the entire clinical research value chain, from patient recruitment to sophisticated data interpretation. The company leverages insights from key opinion leaders and renowned researchers across multiple institutions to refine its methods and data analysis solutions, focusing on unique patient characteristics that influence treatment response.
How much funding has Cognivia raised?
Cognivia has raised a total of $16.5M across 1 funding round:
Other Financing Round
$16.5M
Other Financing Round (2024): $16.5M with participation from Vesalius Biocapital Partners
Key Investors in Cognivia
Vesalius Biocapital Partners
Vesalius Biocapital Partners is a European venture capital firm specializing in innovative life science companies. They invest across all development stages, with a particular interest in early-stage projects possessing strong proprietary technology and skilled teams, focusing on therapeutics, medical devices, and diagnostics.
What's next for Cognivia?
The recent major strategic investment positions Cognivia for significant expansion and further development of its innovative clinical research solutions. This capital infusion is expected to fuel advancements in their data analysis capabilities and broaden their market reach, ultimately aiming to improve patient outcomes by expediting the delivery of new treatments. The company's focus on personalized medicine and optimizing the drug development pipeline suggests a trajectory towards becoming a leader in clinical trial efficiency and patient-centric therapeutic development.
See full Cognivia company page
